Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors

by biblioteca on 27 d'abril de 2026 with No hi ha comentaris

Melero, I., Steeghs, N., Lassen, U., Homicsko, K., Tabernero, J., Cañamero, M., … Charo, J. (2026). Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors. Journal for Immunotherapy of Cancer, 14(1), Article e012885. https://doi.org/10.1136/jitc-2025-012885